JP2016515815A5 - - Google Patents

Download PDF

Info

Publication number
JP2016515815A5
JP2016515815A5 JP2016502986A JP2016502986A JP2016515815A5 JP 2016515815 A5 JP2016515815 A5 JP 2016515815A5 JP 2016502986 A JP2016502986 A JP 2016502986A JP 2016502986 A JP2016502986 A JP 2016502986A JP 2016515815 A5 JP2016515815 A5 JP 2016515815A5
Authority
JP
Japan
Prior art keywords
lipid
nucleic acid
alkyl
composition according
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502986A
Other languages
English (en)
Japanese (ja)
Other versions
JP6605446B2 (ja
JP2016515815A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/029116 external-priority patent/WO2014172045A1/en
Publication of JP2016515815A publication Critical patent/JP2016515815A/ja
Publication of JP2016515815A5 publication Critical patent/JP2016515815A5/ja
Application granted granted Critical
Publication of JP6605446B2 publication Critical patent/JP6605446B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502986A 2013-03-15 2014-03-14 形質移入用の脂質ナノ粒子および関連方法 Active JP6605446B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798495P 2013-03-15 2013-03-15
US61/798,495 2013-03-15
PCT/US2014/029116 WO2014172045A1 (en) 2013-03-15 2014-03-14 Lipid nanoparticles for transfection and related methods

Publications (3)

Publication Number Publication Date
JP2016515815A JP2016515815A (ja) 2016-06-02
JP2016515815A5 true JP2016515815A5 (enExample) 2017-04-06
JP6605446B2 JP6605446B2 (ja) 2019-11-13

Family

ID=51731753

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016502986A Active JP6605446B2 (ja) 2013-03-15 2014-03-14 形質移入用の脂質ナノ粒子および関連方法

Country Status (6)

Country Link
US (2) US10342760B2 (enExample)
EP (1) EP2971013B1 (enExample)
JP (1) JP6605446B2 (enExample)
CN (1) CN105143456A (enExample)
CA (1) CA2906732C (enExample)
WO (1) WO2014172045A1 (enExample)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201690675A1 (ru) 2013-10-03 2016-08-31 Модерна Терапьютикс, Инк. Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности
DK4023249T3 (da) 2014-04-23 2025-01-13 Modernatx Inc Nukleinsyrevacciner
WO2016010840A1 (en) * 2014-07-16 2016-01-21 Novartis Ag Method of encapsulating a nucleic acid in a lipid nanoparticle host
JP6764870B2 (ja) * 2015-02-24 2020-10-07 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア 連続フローマイクロ流体システム
WO2016165825A1 (en) 2015-04-13 2016-10-20 Curevac Ag Method for producing rna compositions
USD771834S1 (en) 2015-04-28 2016-11-15 University Of British Columbia Microfluidic cartridge
USD772427S1 (en) 2015-04-28 2016-11-22 University Of British Columbia Microfluidic cartridge
JP2018525209A (ja) * 2015-04-28 2018-09-06 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア 使い捨てマイクロ流体カートリッジ
USD771833S1 (en) 2015-04-28 2016-11-15 University Of British Columbia Microfluidic cartridge
US12150980B2 (en) 2015-07-30 2024-11-26 Modernatx, Inc. Concatemeric peptide epitope RNAs
DK3350157T3 (da) 2015-09-17 2022-02-14 Modernatx Inc Forbindelser og sammensætninger til intracellulær afgivelse af terapeutiske midler
WO2017070624A1 (en) 2015-10-22 2017-04-27 Modernatx, Inc. Tropical disease vaccines
MA52645B1 (fr) 2015-10-22 2022-06-30 Modernatx Inc Vaccins contre le virus respiratoire
MA46316A (fr) 2015-10-22 2021-03-24 Modernatx Inc Vaccin contre le cytomégalovirus humain
MD3386484T2 (ro) * 2015-12-10 2022-11-30 Modernatx Inc Compoziții și metode de livrare a unor agenți terapeutici
AU2016377681B2 (en) 2015-12-22 2021-05-13 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
JP7349788B2 (ja) 2016-01-06 2023-09-25 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア 分岐ミキサー並びにその使用及び製造方法
CN105622473B (zh) * 2016-02-06 2017-07-25 吴国球 一种阳离子氨基脂质及其合成方法和用途
AU2017266932B2 (en) * 2016-05-18 2023-04-20 Modernatx, Inc. Polynucleotides encoding alpha-galactosidase A for the treatment of Fabry disease
AU2017286606A1 (en) 2016-06-14 2018-12-13 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
CA3027643C (en) 2016-07-06 2021-01-19 Precision Nanosystems Inc Smart microfluidic mixing instrument and cartridges
WO2018064755A1 (en) * 2016-10-03 2018-04-12 Precision Nanosystems Inc. Compositions for transfecting resistant cell types
WO2018075980A1 (en) 2016-10-21 2018-04-26 Modernatx, Inc. Human cytomegalovirus vaccine
US11583504B2 (en) 2016-11-08 2023-02-21 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
US10925958B2 (en) 2016-11-11 2021-02-23 Modernatx, Inc. Influenza vaccine
EP3595713A4 (en) 2017-03-15 2021-01-13 ModernaTX, Inc. Respiratory syncytial virus vaccine
AU2018234692B2 (en) 2017-03-15 2022-06-02 Modernatx, Inc. Compounds and compositions for intracellular delivery of therapeutic agents
ES2911186T3 (es) 2017-03-15 2022-05-18 Modernatx Inc Formas cristalinas de aminolípidos
CA3055653A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Lipid nanoparticle formulation
EP3607074A4 (en) 2017-04-05 2021-07-07 Modernatx, Inc. REDUCTION OR ELIMINATION OF IMMUNE RESPONSES TO NON-INTRAVENOUS THERAPEUTIC PROTEINS, FOR EXAMPLE SUBCUTANEOUSLY
WO2018232120A1 (en) 2017-06-14 2018-12-20 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
US11786607B2 (en) 2017-06-15 2023-10-17 Modernatx, Inc. RNA formulations
CN107488137B (zh) * 2017-08-15 2019-03-29 浙江大学 一种小分子量的季铵盐及其制备方法和应用
MX2020002348A (es) 2017-08-31 2020-10-08 Modernatx Inc Métodos de elaboración de nanopartículas lipídicas.
MY204993A (en) * 2017-09-29 2024-09-26 Intellia Therapeutics Inc Formulations
US11911453B2 (en) 2018-01-29 2024-02-27 Modernatx, Inc. RSV RNA vaccines
CA3097203C (en) * 2018-04-29 2023-09-05 Precision Nanosystems Inc. Compositions for transfecting resistant cell types
CA3113025A1 (en) 2018-09-19 2020-03-26 Modernatx, Inc. Peg lipids and uses thereof
US12263248B2 (en) 2018-09-19 2025-04-01 Modernatx, Inc. Compounds and compositions for intracellular delivery of therapeutic agents
EP4509118A3 (en) * 2018-09-19 2025-05-14 ModernaTX, Inc. High-purity peg lipids and uses thereof
US12090235B2 (en) 2018-09-20 2024-09-17 Modernatx, Inc. Preparation of lipid nanoparticles and methods of administration thereof
KR20210093232A (ko) * 2018-10-09 2021-07-27 더 유니버시티 오브 브리티시 콜롬비아 유기용매와 세제가 없는 형질감염 적격 소포를 포함하는 조성물과 시스템 및 관련 방법
WO2020160430A1 (en) * 2019-01-31 2020-08-06 Modernatx, Inc. Vortex mixers and associated methods, systems, and apparatuses thereof
AU2020260280B2 (en) * 2019-04-15 2023-06-29 Global Life Sciences Solutions Canada Ulc Nonviral modification of t cell gene expression
CA3154618A1 (en) 2019-09-19 2021-03-25 Modernatx, Inc. Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
CN115778904B (zh) * 2019-10-29 2025-03-28 珠海丽凡达生物技术有限公司 一种用于体外转染和体内递送mRNA的制剂
JP2023513043A (ja) 2020-01-31 2023-03-30 モデルナティエックス インコーポレイテッド 脂質ナノ粒子を調製する方法
JP2023522249A (ja) 2020-04-22 2023-05-29 ビオンテック・ソシエタス・エウロパエア コロナウイルスワクチン
EP3915544A1 (en) * 2020-05-25 2021-12-01 Leon-Nanodrugs GmbH Method for producing a liposome dispersion
GB202011367D0 (en) * 2020-07-22 2020-09-02 Micropore Tech Limited Method of preparing liposomes
CA3189854A1 (en) 2020-08-06 2022-02-10 Modernatx, Inc. Compositions for the delivery of payload molecules to airway epithelium
KR20230167008A (ko) 2020-08-06 2023-12-07 모더나티엑스, 인크. 지질 나노입자의 제조 방법
US11406703B2 (en) 2020-08-25 2022-08-09 Modernatx, Inc. Human cytomegalovirus vaccine
AU2021377895A1 (en) 2020-11-13 2023-06-15 Modernatx, Inc. Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
DE102020214601A1 (de) 2020-11-19 2022-05-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Verfahren und Vorrichtung zur Herstellung einer Flüssigkeit enthaltend Liposomen und hergestellte Flüssigkeit
US11524023B2 (en) 2021-02-19 2022-12-13 Modernatx, Inc. Lipid nanoparticle compositions and methods of formulating the same
JP2024527940A (ja) 2021-07-26 2024-07-26 モデルナティエックス インコーポレイテッド ペイロード分子を気道上皮に送達するための脂質ナノ粒子組成物を調製するプロセス
EP4376814A1 (en) 2021-07-26 2024-06-05 ModernaTX, Inc. Processes for preparing lipid nanoparticle compositions
EP4379055A4 (en) 2021-07-27 2025-08-06 Sk Bioscience Co Ltd MRNA FOR PROTEIN EXPRESSION AND TEMPLATE FOR IT
CN115671294A (zh) * 2021-07-27 2023-02-03 中国医学科学院基础医学研究所 St类脂质化合物在制备核酸递送试剂中的应用及相关产品
TW202332467A (zh) 2021-10-29 2023-08-16 美商現代公司 脂質胺
US20250049727A1 (en) 2021-11-12 2025-02-13 Modernatx, Inc. Compositions for the delivery of payload molecules to airway epithelium
US12186387B2 (en) 2021-11-29 2025-01-07 BioNTech SE Coronavirus vaccine
EP4475882A1 (en) 2022-02-09 2024-12-18 ModernaTX, Inc. Mucosal administration methods and formulations
CN119136789A (zh) * 2022-03-28 2024-12-13 日油株式会社 包封核酸的脂质纳米粒子的制造方法和包括该制造方法的药物组合物的制造方法,以及将核酸导入细胞内或靶细胞内的方法
US11878055B1 (en) 2022-06-26 2024-01-23 BioNTech SE Coronavirus vaccine
IT202200016386A1 (it) * 2022-08-02 2024-02-02 Univ Degli Studi Roma La Sapienza Nanoparticelle lipidiche multicomponenti ad elevata fusogenicità cellulare per la veicolazione di acidi nucleici e relativo processo di preparazione
WO2024197404A1 (en) * 2023-03-30 2024-10-03 Ho Emmanuel Abraham Bacteria-responsive particles, methods for preparation, and use in packaging or on surfaces
US12311033B2 (en) 2023-05-31 2025-05-27 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
CN117070570A (zh) * 2023-08-28 2023-11-17 南通大学 提高脂质体转染试剂的转染效率的方法
EP4516295A1 (en) * 2023-09-04 2025-03-05 ETH Zurich Ph-inducible structure-switching lipid nanovectors, semi-synthetic extracellular vesicles, methods of making same and uses thereof
WO2025063214A1 (ja) * 2023-09-22 2025-03-27 国立大学法人東北大学 核酸を内封したリガンド修飾脂質ナノ粒子の製造方法

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981501A (en) 1995-06-07 1999-11-09 Inex Pharmaceuticals Corp. Methods for encapsulating plasmids in lipid bilayers
US7422902B1 (en) 1995-06-07 2008-09-09 The University Of British Columbia Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
NZ333346A (en) 1996-06-28 2000-03-27 Caliper Techn Corp High-throughput screening assay systems in microscale fluidic devices
WO1998033585A1 (en) 1997-02-05 1998-08-06 California Institute Of Technology Microfluidic sub-millisecond mixers
DE69841002D1 (de) 1997-05-14 2009-09-03 Univ British Columbia Hochwirksame verkapselung von nukleinsäuren in lipidvesikeln
US6835395B1 (en) 1997-05-14 2004-12-28 The University Of British Columbia Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
US6534018B1 (en) 1998-11-13 2003-03-18 Optime Therapeutics, Inc. Method and apparatus for liposome production
EP1203614A1 (de) 2000-11-03 2002-05-08 Polymun Scientific Immunbiologische Forschung GmbH Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln
US8137699B2 (en) 2002-03-29 2012-03-20 Trustees Of Princeton University Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
WO2002087541A1 (en) * 2001-04-30 2002-11-07 Protiva Biotherapeutics Inc. Lipid-based formulations for gene transfer
WO2003011443A2 (en) 2001-07-27 2003-02-13 President And Fellows Of Harvard College Laminar mixing apparatus and methods
US7252928B1 (en) 2002-03-12 2007-08-07 Caliper Life Sciences, Inc. Methods for prevention of surface adsorption of biological materials to capillary walls in microchannels
US7901939B2 (en) 2002-05-09 2011-03-08 University Of Chicago Method for performing crystallization and reactions in pressure-driven fluid plugs
AU2003237864B2 (en) 2002-05-15 2008-12-18 California Pacific Medical Center Delivery of nucleic acid-like compounds
US7901708B2 (en) 2002-06-28 2011-03-08 Protiva Biotherapeutics, Inc. Liposomal apparatus and manufacturing methods
JP2006507921A (ja) 2002-06-28 2006-03-09 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 流体分散のための方法および装置
US7214348B2 (en) 2002-07-26 2007-05-08 Applera Corporation Microfluidic size-exclusion devices, systems, and methods
CA2520864A1 (en) 2003-03-31 2004-10-21 Alza Corporation Lipid particles having asymmetric lipid coating and method of preparing same
US7160025B2 (en) 2003-06-11 2007-01-09 Agency For Science, Technology And Research Micromixer apparatus and methods of using same
CA2536360C (en) 2003-08-28 2013-08-06 Celula, Inc. Methods and apparatus for sorting cells using an optical switch in a microfluidic channel network
EP1664316B1 (en) 2003-09-15 2012-08-29 Protiva Biotherapeutics Inc. Polyethyleneglycol-modified lipid compounds and uses thereof
EP1677765A1 (en) 2003-10-24 2006-07-12 Alza Corporation Preparation of lipid particles
EP1537858A1 (en) 2003-12-04 2005-06-08 Vectron Therapeutics AG Drug delivery vehicles and uses thereof
US7507380B2 (en) 2004-03-19 2009-03-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Microchemical nanofactories
CA2566559C (en) 2004-05-17 2014-05-06 Inex Pharmaceuticals Corporation Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
JP4764426B2 (ja) 2004-06-07 2011-09-07 プロチバ バイオセラピューティクス インコーポレイティッド カチオン性脂質および使用方法
US7871632B2 (en) 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
AU2005281352B2 (en) 2004-09-09 2011-01-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal compositions of glucocorticoid and glucocorticoid derivatives
US7622509B2 (en) 2004-10-01 2009-11-24 Velocys, Inc. Multiphase mixing process using microchannel process technology
EP1679115A1 (en) 2005-01-07 2006-07-12 Corning Incorporated High performance microreactor
CA2602493C (en) 2005-03-23 2015-03-17 Velocys, Inc. Surface features in microprocess technology
US20060219307A1 (en) 2005-03-31 2006-10-05 National Taiwan University Micromixer apparatus and method therefor
JP5639338B2 (ja) 2005-07-27 2014-12-10 プロチバ バイオセラピューティクス インコーポレイティッド リポソームの製造システムおよび製造方法
EP1934246B8 (en) 2005-10-07 2012-02-08 Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. Matrix metalloproteinase 11 vaccine
US20070087045A1 (en) * 2005-10-14 2007-04-19 Industrial Technology Research Institute Lipid carrier and method of preparing the same
JP2007252979A (ja) 2006-03-20 2007-10-04 National Institute Of Advanced Industrial & Technology マイクロリアクタによる化合物の製造方法、そのマイクロリアクタ、及びマイクロリアクタ用の分流器
US7794136B2 (en) 2006-05-09 2010-09-14 National Tsing Hua University Twin-vortex micromixer for enforced mass exchange
WO2007150030A2 (en) 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
WO2008053988A1 (fr) 2006-11-02 2008-05-08 National University Corporation Nagoya University Procédé de production de microcapsules
CN101209243B (zh) 2006-12-29 2010-12-08 石药集团中奇制药技术(石家庄)有限公司 一种脂质体药物及其制备方法
US10016451B2 (en) 2007-05-31 2018-07-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
WO2009002152A1 (en) 2007-06-26 2008-12-31 Micronit Microfluidics B.V. Device and method for fluidic coupling of fluidic conduits to a microfluidic chip, and uncoupling thereof
US20110117125A1 (en) 2008-01-02 2011-05-19 Tekmira Pharmaceuticals Corporation Compositions and methods for the delivery of nucleic acids
US8414182B2 (en) 2008-03-28 2013-04-09 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Micromixers for nanomaterial production
US8058069B2 (en) 2008-04-15 2011-11-15 Protiva Biotherapeutics, Inc. Lipid formulations for nucleic acid delivery
US8187554B2 (en) 2008-04-23 2012-05-29 Microfluidics International Corporation Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems
US20110182994A1 (en) 2008-07-25 2011-07-28 S.K. Pharmaceuticals, Inc. Methods and systems for production of nanoparticles
CN105152939A (zh) 2008-11-10 2015-12-16 阿尔尼拉姆医药品有限公司 用于递送治疗剂的脂质和组合物
EP3243504A1 (en) * 2009-01-29 2017-11-15 Arbutus Biopharma Corporation Improved lipid formulation
KR20230098713A (ko) * 2009-06-10 2023-07-04 알닐람 파마슈티칼스 인코포레이티드 향상된 지질 조성물
US9029338B2 (en) * 2009-08-14 2015-05-12 Alnylam Pharmaceuticals, Inc. Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
WO2011038073A1 (en) 2009-09-23 2011-03-31 Formatech, Inc. Methods for the preparation of liposomes comprising docetaxel
JP5823405B2 (ja) * 2009-11-04 2015-11-25 ザ ユニバーシティ オブ ブリティッシュ コロンビア 核酸含有脂質粒子および関連方法
WO2012000104A1 (en) 2010-06-30 2012-01-05 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
US20130323269A1 (en) * 2010-07-30 2013-12-05 Muthiah Manoharan Methods and compositions for delivery of active agents
US8361415B2 (en) 2010-09-13 2013-01-29 The Regents Of The University Of California Inertial particle focusing system

Similar Documents

Publication Publication Date Title
JP2016515815A5 (enExample)
JP7753190B2 (ja) 核酸の送達のための改善された脂質ナノ粒子
CN112996519B (zh) 用于核酸的器官特异性递送的组合物和方法
JP6605446B2 (ja) 形質移入用の脂質ナノ粒子および関連方法
EP3986866B1 (en) Ionizable lipids for nucleic acid delivery
JP2016028031A5 (enExample)
CN120360966A (zh) 用于核酸的器官特异性递送的组合物和方法
JP2013510096A5 (enExample)
CN103153347A (zh) 用于寡核苷酸递送的新型低分子量阳离子脂质
CN115297850A (zh) 用于肝纤维化和其他与纤维化相关的疾病的基于外排体的治疗
CN112533643A (zh) 外排体用于靶向递送治疗剂的用途
KR20240099246A (ko) 지질 나노입자(lnp) 조성물 및 이의 사용방법
US20070054873A1 (en) Glucocorticoid modulation of nucleic acid-mediated immune stimulation
JP2025525843A (ja) ハイブリッドペプチドデンドリマー系及び肝外送達
US20250295788A1 (en) Siloxane-based lipids, lipid nanoparticle compositions comprising the same, and methods of use thereof for targeted delivery
US12503432B2 (en) Ionizable lipids for nucleic acid delivery
Luo Development of Lipid-like Nanoparticles for mRNA Delivery
WO2025072150A1 (en) Zwitterionic lipid nanoparticle compositions, and methods of use
AU2023457271A1 (en) Lipid nanoparticle formulations for cell therapy and related methods
WO2025219491A1 (en) Method and composition for hdr template dna delivery
JP2025528441A (ja) 核酸を含む活性剤の送達のための組成物及び方法
KR20250029907A (ko) 백신용 지질 나노입자 제제
WO2025167731A1 (zh) Cd62l作为靶向免疫细胞药物靶点的应用及car药物
Nogueira Development of new DODAX: MO: DC-Chol nanoparticles containing BRAF-siRNA for colorectal cancer therapy
HK40055907A (en) Compositions and methods for organ specific delivery of nucleic acids